(Q53098819)

11 May 2018

title

Checklist for standardized reporting of drug-drug interaction management guidelines. (English)

1 reference

11 May 2018

0 references

4

1 reference

11 May 2018

Robin Ferner

5

1 reference

11 May 2018

Jeffrey Aronson

3

object named as

Jeffrey K Aronson

1 reference

11 May 2018

author name string

Annemieke Floor-Schreudering

1

1 reference

11 May 2018

Arjen F J Geerts

2

1 reference

11 May 2018

Peter A G M De Smet

6

1 reference

11 May 2018

publication date

5 December 2013

1 reference

11 May 2018

European Journal of Clinical Pharmacology

published in

1 reference

11 May 2018

volume

70

1 reference

11 May 2018

page(s)

313-318

1 reference

11 May 2018

issue

3

1 reference

11 May 2018

https://scigraph.springernature.com/pub.10.1007/s00228-013-1612-7

exact match

0 references

cites work

From best evidence to best practice: effective implementation of change in patients' care

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1612-7

Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1612-7

Development and application of a generic methodology to assess the quality of clinical guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1612-7

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1612-7

Management of potential drug interactions in community pharmacies: a questionnaire-based survey in Switzerland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1612-7

Concordance of severity ratings provided in four drug interaction compendia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1612-7

Clarity and applicability of drug-drug interaction management guidelines: a systematic appraisal by general practitioners and community pharmacists in the Netherlands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1612-7

SFINX—a drug-drug interaction database designed for clinical decision support systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1612-7

The quality of information on monitoring for haematological adverse drug reactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1612-7

Comparative assessment of four drug interaction compendia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1612-7

Clinically significant drug-drug interactions between oral anticancer agents and nonanticancer agents: profiling and comparison of two drug compendia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1612-7

Requirements for a successful implementation of drug interaction information systems in general practice: results of a questionnaire survey in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1612-7

Prescribing indicators for UK general practice: Delphi consultation study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1612-7

Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1612-7

Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1612-7

The Delphi technique: myths and realities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1612-7

Laboratory tests in the clinical risk management of potential drug-drug interactions: a cross-sectional study using drug-dispensing data from 100 Dutch community pharmacies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1612-7

Frequency and nature of drug-drug interactions in a Dutch university hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1612-7

Practice guidelines developed by specialty societies: the need for a critical appraisal

21 January 2018

1 reference

12 December 2020

Compliance with National Guidelines for the Management of Drug–Drug Interactions in Dutch Community Pharmacies

1 reference

12 December 2020

Identification of serious drug-drug interactions: results of the partnership to prevent drug-drug interactions

1 reference

12 December 2020

Quality of drug interaction alerts in prescribing and dispensing software

1 reference

12 December 2020

Clinical relevance of drug-drug interactions : a structured assessment procedure

1 reference

12 December 2020

Consensus-based evaluation of clinical significance and management of anticancer drug interactions

1 reference

12 December 2020

Recommendations for generating, evaluating, and implementing drug-drug interaction evidence

1 reference

12 December 2020

Metadata-driven Delphi rating on the Internet

1 reference

12 December 2020

Standardized reporting of clinical practice guidelines: a proposal from the Conference on Guideline Standardization

1 reference

12 December 2020

Drug interaction management

1 reference

12 December 2020

10.1007/S00228-013-1612-7

Identifiers

DOI

1 reference

11 May 2018

PubMed ID

24306496

1 reference

11 May 2018